ClinicalTrials.govpublic full text
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
neoplasms, kidney neoplasms, urologic neoplasms, urogenital neoplasms, female urogenital diseases, male urogenital diseases
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 143539
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.